<DOC>
	<DOCNO>NCT00631332</DOCNO>
	<brief_summary>The Women 's Health Initiative Study Cognitive Aging ( WHISCA ) two-armed , randomize , placebo control , clinical trial design assess efficacy postmenopausal hormone therapy ( HT ) age relate change specific cognitive function . WHISCA ancillary study Women 's Health Initiative ( WHI ) WHI Memory Study ( WHIMS ) enrol 2303 woman age 66 84 year meet criterion dementia . WHISCA investigate effect hormone therapy rate change time memory , aspects cognition ( language , attention , spatial ability ) , motor function , mood . Objectives - Does HT protect age-associated memory cognitive longitudinal decline woman age 65 old ? - What rate change memory cognitive ability woman receive HT compare woman receive placebo ? - Does addition progesterone HT modify effect estrogen memory cognitive ability ?</brief_summary>
	<brief_title>Women 's Health Initiative Study Cognitive Aging</brief_title>
	<detailed_description />
	<criteria>Enrolled WHIMS At least 65 year old Not diagnose dementia Women young 65 year age Have dementia enrol WHIMS</criteria>
	<gender>Female</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>woman , dementia , cognition .</keyword>
	<keyword>non-demented woman least age 65</keyword>
</DOC>